Benefits
Supports normal thyroid function
Iodine is needed to make the thyroid hormones T3 and T4, and EU rules allow the claim that iodine contributes to normal thyroid hormone production and thyroid function. IodAid has not been tested itself; with a different brown-seaweed capsule, urine iodine rose in women with low intake. The benefit applies when the diet supplies too little iodine.
Helps maintain normal energy metabolism
Thyroid hormones help set the body's energy use, and EU rules allow the claim that iodine contributes to normal energy-yielding metabolism. This is a general role of iodine for people who would otherwise fall short, not a result measured with IodAid.
Supports normal nervous system and cognitive function
EU rules allow the claims that iodine contributes to normal functioning of the nervous system and to normal cognitive function. These are general roles of iodine, not results from IodAid trials.
Helps maintain normal skin
EU rules allow the claim that iodine contributes to the maintenance of normal skin. This is a general role of iodine for people with low intake, not a result measured with IodAid.
Mechanism of action
Iodine as a thyroid hormone substrate
Iodine is incorporated into thyroglobulin in the thyroid gland to form the hormones T3 and T4. Supplying iodine helps ensure the raw material needed for normal thyroid hormone synthesis is available.
Naturally bound seaweed iodine
IodAid is made by concentrating minerals from brown seaweed by-products with a water-based process, so its iodine comes from seaweed rather than from added potassium iodide. In one study, iodine from a different brown seaweed was about half as available as iodine from potassium iodide (33 versus 59 percent of the dose).
Accompanying seaweed fucoidan
The higher-dose form also delivers fucoidan, a sulfated polysaccharide native to brown seaweed that is co-extracted with the iodine; iodine remains the component responsible for the thyroid-related contributions.
Clinical trials
Non-randomized pre-post clinical study with a six-week seaweed-cessation period; seaweed foods, not IodAid (Aakre et al. 2026, Eur J Nutr).
49 healthy adult habitual seaweed consumers in Norway (mean age 47).
Estimated iodine intake fell from a median of 658 to 189 mcg a day after stopping seaweed, and median serum TSH fell from 1.4 to 1.1 mIU/L, with the largest TSH change in those with the highest starting intake; free T3 and T4 did not change. Before stopping, median intake was above the tolerable upper level.
Two-week supplementation study with an iodine absorption comparison against potassium iodide, using an encapsulated Ascophyllum nodosum product (Napiers Hebridean Seagreens), not IodAid (Combet et al. 2014, Br J Nutr).
Healthy non-pregnant women of childbearing age with low dairy and seafood intake (42 in the supplementation phase, 22 in the absorption test).
Iodine from 1 g of seaweed was 33 percent absorbed versus 59 percent from potassium iodide. After 0.5 g a day for two weeks, median urinary iodine rose from 78 to 140 mcg/L and TSH rose from 1.5 to 2.1 mIU/L, with two women above the normal range but normal free thyroxine.